Sparkasse Ulm
VC Fund
Denzlingen, Germany
Sparkasse Ulm is a VC fund in Denzlingen focused on Medical and Health Care. Sparkasse Ulm is provides banking services.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sparkasse Ulm invests in
Stages Sparkasse Ulm invests in
Countries Sparkasse Ulm invests in
Investment Focus
Industry
- Medical 1 (50%)
- Health Care 1 (50%)
- Medical Device 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware intoscalable products.Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact. | $26.1M / Series B / Dec 20, 2024 | ||
| NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware intoscalable products.Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact. | $30M / Series A / Jun 22, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Sparkasse Ulm invest in?
Sparkasse Ulm invests primarily in Medical, Health Care and Medical Device startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sparkasse Ulm last invest?
The most recent investment recorded for Sparkasse Ulm closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
